Amgen, Inc. (AMGN)
340.16
-5.26
(-1.52%)
USD |
NASDAQ |
Dec 04, 16:00
341.52
+1.36
(+0.40%)
After-Hours: 20:00
Amgen Market Cap: 183.17B for Dec. 4, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 26.70B |
| Gilead Sciences, Inc. | 152.13B |
| Johnson & Johnson | 487.83B |
| Eli Lilly & Co. | 907.99B |
| Regeneron Pharmaceuticals, Inc. | 75.97B |
Market Cap Related Metrics
| PE Ratio | 26.30 |
| PS Ratio | 5.132 |
| PEG Ratio | 0.4007 |
| Price to Book Value | 19.04 |
| Price to Free Cash Flow | 15.96 |
| Price | 340.16 |
| Earnings Yield | 3.80% |
| PEGY Ratio | 0.3843 |
| Operating PE Ratio | 17.97 |
| Normalized PE Ratio | 22.67 |